Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

<h4>Objective</h4> To determine the cost effectiveness of molecular monitoring in patients with chronic myeloid leukemia in the chronic phase (CML-CP) compared to no molecular monitoring from a Chinese payer perspective. <h4>Methods</h4> Analyses were conducted using a semi-M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan, Tengbin Xiong, Yu Liu, Ricardo Viana
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9736bccd0e28441da05c8d7f160fa01a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!